This year’s Drug Discovery Innovation Programme will highlight the challenges discovery pipelines have faced due to COVID-19 and will put a spotlight on the adoption of technology to finding the solutions.
With over 100+ attendees, learn how modernization in R&D processes is fundamentally changing what the drug discovery research will look like in the next two to five years.
So, join us in May 2022 for an in-person experience and 2-days of top-level strategic content and the current scientific insights, networking, and discussions from leading global pharmaceutical R&D executives.
ROAD TO AI
LEAD GENERATION STRATEGIES
ADVANCES IN DRUG DESIGN
RNA THERAPEUTICS ON THE RISE
SMALL MOLECULES IN DRUG DISCOVERY
TRANSLATING OMICS INTO THERAPEUTICS
PRECLINICAL STRATEGIES, MODELS AND TOOLS
COLLABORATE TO ACCELERATE
HIT TRIAGE AND VALIDATION STRATEGIES
MEDICINAL CHEMISTRY TOOLBOX
NOVEL DRUG TARGET DISCOVERY & VALIDATION
Meet our professonals
Research Fellow | Formulation/Delivery Group Leader | Founding Oral Peptide Delivery Platform Leader
Eli Lilly and Company
Strategic and Technical Advisor, Chief Data & AI Office
Principal Scientist II, Lead of Structure Based Drug Design
Kadmon Holdings, Inc.
Chief Drug Hunter & President
Principal Scientist, Experimental Biology
SAI LIFE SCIENCES LTD
what people say
companies that support us
see what we did lately